Molecular Imaging: Page 84

Is PET radiotracer uptake in lymph nodes after COVID-19 vaccination associated with age?

By Will Morton

Monday, November 29 | 9:30 a.m.-10:30 a.m. | SSNMMI03-6 | Room S402Israeli researchers will offer findings in this presentation on PET/CT uptake in the deltoid muscle and axillary lymph nodes in patients who received COVID-19 mRNA-based vaccines. The group explored whether uptake is associated with patient age and immune status.

November 22, 2021

PET with F-18 fluoroestradiol tracer evaluated in women with breast cancer

By Will Morton

Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-2 | Room N226In this talk, researchers will discuss results of the first prospective study evaluating the performance of F-18 fluoroestradiol PET/CT in women with invasive lobular carcinoma breast cancer.

November 22, 2021

Ultrafast low-dose PET/CT equivalent to conventional imaging for cancer

By Will Morton

Sunday, November 28 | 2:30 p.m.-3:30 p.m. | SSNMMI02-2 | Room N226In this session covering technical advances in molecular imaging, researchers will present findings of a prospective phase III trial comparing an ultrafast, low-dose, whole-body FDG-PET/CT approach with conventional imaging in patients with cancer.

November 22, 2021

PET tracers can verify patient response to HIFU treatment

By Will Morton

Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-5 | Room N226In this molecular oncologic imaging presentation, researchers will report on the use of gallium-68-based radiotracers to assess response to high-intensity focused ultrasound (HIFU) therapy in prostate cancer patients.

November 22, 2021

Combining radiomics, AI with PET/MRI helps assess nodal status

By Amerigo Allegretto

Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-3 | Room N226Here, researchers will talk about how applying radiomics and machine learning to FDG-PET/MRI can noninvasively assess nodal status and treatment planning for breast cancer patients.

November 21, 2021

Monrol and MTTI ink Lu-177 supply deal

By AuntMinnie.com staff writers

EczacıbaŞı-Monrol Nuclear Products has signed an agreement to supply Molecular Targeting Technologies (MTTI) with no-carrier-added lutetium-177 (Lu-177).

November 18, 2021

PSMA-PET predicts patient response to chemotherapy

By Will Morton

PET imaging with a radiotracer based on prostate-specific membrane antigen (PSMA) can help predict whether patients with metastatic prostate cancer will respond to chemotherapy, a significant finding in efforts to tailor therapy to individual patients, according to a study published November 12 in the Journal of Nuclear Medicine.

November 18, 2021

NorthStar to buy accelerator for actinium-225 production

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes has inked a deal with Ion Beam Applications (IBA) to purchase one of IBA's Rhodotron TT300 HE electron-beam accelerators for the commercial production of actinium-225 (Ac-225) at its new production facility in Beloit, WI.

November 17, 2021

Emory's Meltzer tapped to lead USC medical school

By AuntMinnie.com staff writers

Dr. Carolyn Meltzer of Emory University has been named as dean of the Keck School of Medicine at the University of Southern California (USC).

November 16, 2021

MIM gets FDA nod for molecular radiotherapy software

By AuntMinnie.com staff writers

Medical imaging software developer MIM software has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its SurePlan MRT molecular radiotherapy software.

November 16, 2021

PET/MRI shows prowess for nodal staging in breast cancer

By Amerigo Allegretto

Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-4 | Room TBAIn this presentation, researchers will compare nodal staging between CT, MRI, and FDG-PET/MRI in patients with newly diagnosed breast cancer.

November 15, 2021

Combining radiomics, AI with PET/MRI helps assess nodal status

By Amerigo Allegretto

Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-3 | Room TBAHere, researchers will talk about how applying radiomics and machine learning to FDG-PET/MRI can noninvasively assess nodal status and treatment planning for breast cancer patients.

November 15, 2021

Previous Page

Page 84 of 614

Next Page